lifestyle.longislandreport.org

Author: Alzheimer’s Drug Discovery Foundation

ADDF Launches New Phase of $150 Million Diagnostics Accelerator Initiative to Power Next Generation of Alzheimer’s Precision Medicine Worldwide

March 17, 2026
Alzheimer’s Drug Discovery Foundation Appoints Isobel Coleman as Chief Executive Officer to Lead Next Era of Alzheimer’s Breakthroughs

March 11, 2026
ADDF Awards Prestigious 2026 Melvin R. Goodes Prize to Alzheimer’s Research Pioneer Randall J. Bateman, MD

February 18, 2026
ADDF Bolsters Leadership Amid Transformative Moment in Alzheimer’s Research, Naming Gavin Cook and David Dolby to its Board and Appointing Jane McIntosh as Interim CEO

December 17, 2025
New Data from Semaglutide Trials Provides Critical Insights to Guide Next Generation of Therapies Targeting Alzheimer’s Pathobiology

December 5, 2025
Readout of Phase 3 Semaglutide Trials Marks Critical Moment in Alzheimer’s Research and Suggests Potential for Combination Therapies

November 24, 2025
Alzheimer’s Drug Discovery Foundation Launches Milestones in Motion Campaign and Announces Fifth Season of Symposium Series in Palm Beach

November 21, 2025
Landmark JPAD Special Issue Highlights How Combination Therapies, Underpinned by New Era of Research, Are Poised to Redefine Alzheimer’s Treatment

November 16, 2025